Clin2
NCT06446908Possibly a fitNot yet recruiting

New approach to help people with fatty liver get active

Liver SteatosisMASHMASLD

Part of Digestive system clinical trials.

This study tests a new way to help people with fatty liver disease (MASLD or MASH) become more physically active. You'll use a computer to participate, and the goal is to see if this approach is acceptable and helpful for people like you.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
12 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have a type of fatty liver disease called MASLD or MASH, but not cirrhosis (scarring).
  • You have a computer with internet access at home.
  • You do not have another cause of liver disease or cirrhosis.
  • You drink less than 50 grams of alcohol per week (about 3-4 drinks).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06334666Enrolling by invitation
Step counting for fatty liver disease management

This trial tests if using a pedometer to track daily steps can help people with a type of fatty liver disease (called MASLD) become more active and improve their health. It may be a good fit if you are not already very active and want to try a simple way to manage your condition.

Bangkoknoi, Bangkok
NCT06826807Enrolling by invitation
Lifestyle change study for fatty liver disease

This study tests whether adding a liver stiffness measurement to a lifestyle program helps people with MASLD (a type of fatty liver disease) improve their liver health. It is designed for people who have fatty liver and at least one sign of metabolic syndrome, like high blood pressure or diabetes.

Bangkoknoi, Bangkok
NCT04873258Recruiting
Test a non-invasive tool to screen for fat-related liver disease

This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.

London, London
NCT07382349Recruiting
Decision support tools for fatty liver disease

This study tests electronic tools to help doctors identify and care for patients with steatotic liver disease (fatty liver). If you have risk factors like diabetes or elevated liver enzymes, this trial may help improve your care.

Nashville, Tennessee
NCT06920316Not yet recruiting· Phase 4
Digital diet and exercise for liver scarring in fatty liver disease

This trial tests whether a digital diet and exercise program can reduce liver scarring in people with MASLD (fatty liver disease not caused by alcohol). You would use an app on your smartphone to follow the program at home.

London, London
NCT07467512Not yet recruiting
Exercise for an aging liver (EXALIVER) study

This study tests whether a structured exercise program can help improve liver health in adults with fatty liver disease. If you have metabolic-related fatty liver and are not already very active, you may be a good candidate.

Madrid

Hear when a new MASLD trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.